Suchergebnisse - "Kita, Kenji"

PubPharm (47)

1

Generic UPLC-MS/MS and Gyrolab assays with blood microsampling for pharmacokinetic assessments of therapeutic antibodies in mice

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Mano, Y. | Kita, K. | Tsugaru, M. | +3

2

Determination of individual factors associated with hallux valgus using SVM-RFE

enthalten in: BMC musculoskeletal disorders | 2023

von Nakao, H. | Imaoka, M. | Hida, M. | +4

3

Determination of individual factors associated with hallux valgus using SVM-RFE

enthalten in: BMC musculoskeletal disorders | 2023

von Nakao, H. | Imaoka, M. | Hida, M. | +4

4

Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer

enthalten in: The Journal of pathology | 2022

von Yamamoto, D. | Oshima, H. | Wang, D. | +11

5

Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells

enthalten in: Cancer medicine | 2022

von Katayama, Y. | Yamada, T. | Tokuda, S. | +11

6

Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR‐T790M mutation in non‐small cell lung cancer cells

enthalten in: Cancer Medicine | 2022

von Katayama, Y. | Yamada, T. | Tokuda, S. | +11

7

Characterization of RNF43 frameshift mutations that drive Wnt ligand‐ and R‐spondin‐dependent colon cancer

enthalten in: The Journal of Pathology | 2022

von Yamamoto, D. | Oshima, H. | Wang, D. | +11

8

FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells

enthalten in: Oncogene | 2021

von Tsuji, T. | Maeda, Y. | Kita, K. | +6

9

Quantitative and qualitative application of a novel capillary microsampling device, Microsampling Wing™ (MSW), using antiepileptic drugs in rats

enthalten in: Journal of pharmaceutical and biomedical analysis | 2021

von Hotta, K. | Ishida, T. | Noritake, K. | +2

10

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

enthalten in: Nature communications | 2020

von Wang, R. | Yamada, T. | Kita, K. | +24

1
2
3
4
5
Nächster »
[5]